Back to Search
VIPULKUMAR RANA, M.D.
M.D.
Internal Medicine Physician
NPI: 1831289115IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
50521(WI)
Education
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE
Class of 2004
Research & Publications (20)
Risk of intracranial hemorrhage and cerebrovascular accidents in non-small cell lung cancer brain metastasis patients.
PMID 19190519·J Thorac Oncol·2009
4-observational
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
PMID 19332725·J Clin Oncol·2009
3-trial
1-Arylmethyl-2,3-dioxo-2,3-dihydroindole thiosemicarbazones as leads for developing cytotoxins and anticonvulsants.
PMID 18608748·J Enzyme Inhib Med Chem·2009
7-preclinical
Understanding the mechanism for paradoxical effect of ionized and unionized chitosan: Orodispersible tablets of Ondansetron Hydrochloride.
PMID 19241220·Pharm Dev Technol·2009
8-other
Formulation of orodispersible tablets of ondansetron HCl: investigations using glycine-chitosan mixture as superdisintegrant.
PMID 19420882·Yakugaku Zasshi·2009
4-observational
Long-term radiotherapy outcomes for nasal cavity and septal cancers.
PMID 18164845·Int J Radiat Oncol Biol Phys·2008
8-other
Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.
PMID 17980502·Int J Radiat Oncol Biol Phys·2008
8-other
Clinical benefit of palliative radiation therapy in advanced gastric cancer.
PMID 17899453·Acta Oncol·2008
8-other
Orally disintegrating systems: innovations in formulation and technology.
PMID 19075912·Recent Pat Drug Deliv Formul·2008
6-review
A novel approach to optimize and formulate fast disintegrating tablets for nausea and vomiting.
PMID 18584333·AAPS PharmSciTech·2008
4-observational
Preparation and optimization of mouth/orally dissolving tablets using a combination of glycine, carboxymethyl cellulose and sodium alginate: a comparison with superdisintegrants.
PMID 18484492·Pharm Dev Technol·2008
4-observational
Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
PMID 18213725·Head Neck·2008
8-other
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy.
PMID 17538975·Cancer·2007
8-other
Identification of a new hybrid serum response factor and myocyte enhancer factor 2-binding element in MyoD enhancer required for MyoD expression during myogenesis.
PMID 17377068·Mol Biol Cell·2007
7-preclinical
Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding.
PMID 16982699·Mol Cell Biol·2006
7-preclinical
Thermotropic and spectroscopic behavior of skin: relationship with percutaneous permeation enhancement.
PMID 16472099·Curr Drug Deliv·2006
6-review
Autologous peripheral stem cell transplant for POEMS syndrome: a case report.
PMID 17607587·Hematology·2006
5-case
Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation.
PMID 17083124·Cancer·2006
8-other
Lipid synthesis inhibitors: effect on epidermal lipid conformational changes and percutaneous permeation of levodopa.
PMID 16354007·AAPS PharmSciTech·2005
4-observational
Chemical constituents and antioxidant activity of Mallotus roxburghianus leaves.
PMID 17192023·Chem Biodivers·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9200 W WISCONSIN AVE, INTERNAL MEDICINE HOSPITALIST DIVISION
MILWAUKEE, WI 53226 - Phone
- (414) 805-0820
Quick Facts
- NPI
- 1831289115
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile